Ethidium bromide transport across Mycobacterium smegmatis cell-wall: Correlation with antibiotic resistance

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Rodrigues, Liliana ^a   Ramos, Jorge ^a   Couto, Isabel ^a,b   Amaral, Leonard ^a,c   Viveiros, Miguel ^a,c  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c Cost Action BM0701 ^*  (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; CHLORPROMAZINE; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; ETHAMBUTOL; ETHIDIUM BROMIDE; PORIN; PROTEIN MSPA; PROTEIN MSPC; QUATERNARY AMMONIUM DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; THIORIDAZINE; UNCLASSIFIED DRUG; VERAPAMIL; ANTIINFECTIVE AGENT; ANTIPORTER; ETHIDIUM; LFRA PROTEIN, MYCOBACTERIUM SMEGMATIS; MSPA PROTEIN, MYCOBACTERIUM SMEGMATIS; MSPC PROTEIN, MYCOBACTERIUM SMEGMATIS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TRANSPORT; GENE DELETION; MINIMUM INHIBITORY CONCENTRATION; MUTANT; MYCOBACTERIUM SMEGMATIS; NONHUMAN; CELL WALL; DRUG EFFECT; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; TRANSPORT AT THE CELLULAR LEVEL;

MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTIPORTERS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CELL WALL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHIDIUM; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; PORINS; SEQUENCE DELETION;

EID: 79951566410     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-35     Document Type: Article

References (34)

1. The envelope of mycobacteria. PJ Brennan H Nikaido, Annu Rev Biochem 1995 64 29 63 10.1146/annurev.bi.64.070195.000333 7574484
2. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. PJ Brennan, Tuberculosis 2003 83 91 97 10.1016/S1472-9792(02) 00089-6 12758196 (Pubitemid 36683556)
3. Mycobacterial porins - new channel proteins in unique outer membranes. M Niederweis, Mol Microbiol 2003 49 1167 1177 10.1046/j.1365-2958.2003.03662.x 12940978 (Pubitemid 37153488)
4. Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis. M Niederweis S Ehrt C Heinz U Klöcker S Karosi KM Swiderek LW Riley R Benz, Mol Microbiol 1999 33 933 945 10.1046/j.1365-2958.1999.01472.x 10476028 (Pubitemid 29425246)
5. MspA provides the main hydrophilic pathway through the cell wall of Mycobacterium smegmatis. C Stahl S Kubetzko I Kaps S Seeber H Engelhardt M Niederweis, Mol Microbiol 2001 40 451 464 10.1046/j.1365-2958.2001.02394.x 11309127 (Pubitemid 32391639)
6. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. H Nikaido, Semin Cell Dev Biol 2001 12 215 23 10.1006/scdb.2000.0247 11428914
7. World Health Organization, Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response Geneva, Switzerland 2010
8. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. JA Aínsa MC Blokpoel I Otal DB Young KA De Smet C Martín, J Bacteriol 1998 180 5836 5843 9811639 (Pubitemid 28514198)
9. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. BS Choudhuri S Bhakta R Barik J Basu M Kundu P Chakrabarti, Biochem J 2002 367 279 285 10.1042/BJ20020615 12057006 (Pubitemid 35176916)
10. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. E De Rossi JA Aínsa G Riccardi, FEMS Microbiol Rev 2006 30 36 52 10.1111/j.1574-6976.2005.00002.x 16438679
11. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. N Siddiqi R Das N Pathak S Banerjee N Ahmed VM Katoch SE Hasnain, Infection 2004 32 109 111 10.1007/s15010-004-3097-x 15057575 (Pubitemid 38457104)
12. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. S Ramán-García C Martín CJ Thompson JA Aínsa, Antimicrob Agents Chemother 2009 53 3675 3682 19564371
13. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. HE Takiff M Cimino MC Musso T Weisbrod R Martinez MB Delgado L Salazar BR Bloom WR Jacobs Jr, Proc Natl Acad Sci USA 1996 93 362 366 10.1073/pnas.93.1.362 8552639 (Pubitemid 26038159)
14. Mycobacterial efflux pumps and chemotherapeutic implications. M Viveiros C Leandro L Amaral, Int J Antimicrob Agents 2003 22 274 278 10.1016/S0924- 8579(03)00208-5 13678834 (Pubitemid 37103213)
15. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. XZ Li L Zhang H Nikaido, Antimicrob Agents Chemother 2004 48 2415 2423 10.1128/AAC.48.7.2415-2423.2004 15215089 (Pubitemid 38823405)
16. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J Liu HE Takiff H Nikaido, J Bacteriol 1996 178 3791 3795 8682782 (Pubitemid 26227194)
17. Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. P Sander E De Rossi B Böddinghaus R Cantoni M Branzoni EC Böttger H Takiff R Rodriquez G Lopez G Riccardi, FEMS Microbiol Lett 2000 193 19 23 10.1111/j.1574-6968.2000.tb09396.x 11094273
18. Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. M Bellinzoni S Buroni F Schaeffer G Riccardi E De Rossi PM Alzari, J Bacteriol 2009 191 7531 7537 10.1128/JB.00631-09 19820093
19. LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. S Buroni G Manina P Guglierame MR Pasca G Riccardi E De Rossi, Antimicrob Agents Chemother 2006 50 4044 4052 10.1128/AAC.00656-06 17043130 (Pubitemid 44865148)
20. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. MW Jernaes HB Steen, Cytometry 1994 17 302 309 10.1002/cyto.990170405 7875037
21. Single molecule techniques for biomedicine and pharmacology. KO Greulich, Curr Pharm Biotechnol 2004 5 243 259 10.2174/1389201043376878 15180546 (Pubitemid 38821330)
22. An instrument-free method for the demonstration of efflux pump activity of bacteria. M Martins B Santos A Martins M Viveiros I Couto A Cruz JM Pagès J Molnar S Fanning L Amaral Management Committee Members of Cost B16 European Commission/European Science Foundation, In Vivo 2006 20 657 664 17091774 (Pubitemid 44680200)
23. Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. A Schumacher R Trittler JA Bohnert K Kümmerer JM Pagès WV Kern, J Antimicrob Chemother 2007 59 1261 1264 10.1093/jac/dkl380 16971414 (Pubitemid 47073344)
24. Correlation of the base specificity of DNA-intercalating ligands with their physico-chemical properties. D Sharples JR Brown, FEBS Lett 1976 69 37 40 10.1016/0014-5793(76)80648-5 1033085
25. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. L Rodrigues D Wagner M Viveiros D Sampaio I Couto M Vavra WV Kern L Amaral, J Antimicrob Chemother 2008 61 1076 1082 10.1093/jac/dkn070 18310137 (Pubitemid 351524452)
26. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. M Viveiros A Martins L Paixo L Rodrigues M Martins I Couto E Fähnrich WV Kern L Amaral, Int J Antimicrob Agents 2008 31 458 462 10.1016/j.ijantimicag.2007.12.015 18343640
27. Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. M Viveiros L Rodrigues M Martins I Couto G Spengler A Martins L Amaral, Antibiotic Resistance Methods and Protocols (Methods in Molecular Medicine) New York: Humana Press, S. H. Gillespie, 2 2010 642 159 172
28. The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients. J Stephan J Bender F Wolschendorf C Hoffmann E Roth C Mailänder H Engelhardt M Niederweis, Mol Microbiol 2005 58 714 730 10.1111/j.1365-2958.2005.04878.x 16238622 (Pubitemid 41532470)
29. rpsL+: a dominant selectable marker for gene replacement in mycobacteria. P Sander A Meier EC Böttger, Mol Microbiol 1995 16 991 1000 10.1111/j.1365-2958.1995.tb02324.x 7476195
30. Porins are required for uptake of phosphates by Mycobacterium smegmatis. F Wolschendorf M Mahfoud M Niederweis, J Bacteriol 2007 189 2435 2442 10.1128/JB.01600-06 17209034 (Pubitemid 46411358)
31. Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. J Stephan C Mailaender G Etienne M Daffé M Niederweis, Antimicrob Agents Chemother 2004 48 4163 4170 10.1128/AAC.48.11.4163-4170.2004 15504836 (Pubitemid 39434870)
32. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. E Dubnau J Chan C Raynaud VP Mohan MA Laneelle K Yu A Quemard I Smith M Daffé Mol. Microbiol 2000 36 630 637 10.1046/j.1365-2958.2000.01882.x 10844652 (Pubitemid 30258847)
33. Clinical and Laboratory Standards Institute (CLSI), Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard. CLSI M24-A Wayne, PA 2003
34. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. SB Snapper RE Melton S Mustafa T Kieser WR Jacobs Jr, Mol Microbiol 1990 4 1911 1919 10.1111/j.1365-2958.1990.tb02040.x 2082148